Bleeding stent sales
530602
Remember when doctors and their patients practically stood in line waiting for the arrival of new drug-coated stents that promised to make popular procedures to reopen clogged arteries more effective?
35244
A new technique uses a magnetic field to guide potential therapies to stents in clogged blood vessels.
524591
A rundown of funds selling at a discount to the cover price.
741865
Drug-coated heart stents on the U.S. market are associated with a small but significant risk of blood clots months after they are implanted, U.S. Food and Drug Administration staff said in documents released on Tuesday.
687742
New drug-oozing stents widely used to prop open clogged arteries are associated with an increased risk of blood clots, heart attacks and death for the majority of patients receiving the devices, an expert panel concluded yesterday.
308614
Boston Scientific provided fresh evidence in its strong quarterly earnings report Tuesday that it reigns supreme in the market for drug-coated stents.
90989
The medical device maker reported a third-quarter loss of $272 million on charges related to acquisitions and asset sales, as the companyâs top-selling stent continued to slump.
311263
Boston Scientific Corp. BSX.N, whose  Taxus heart device has been involved in a major recall, said on  Wednesday preliminary August sales of the device slowed to $200  million from $207 million reported in July, and issued an  outlook that was below Wall Street estimates.
13632
Slow sales hit a margin-boosting afterburner.
119061
Boston Scientific Corp.  posted a lower-than-expected quarterly profit on Friday as sales of its flagship drug-eluting heart stents fell by 32 percent.
131767
U.S. advisers will start considering on Thursday the risks of drug-coated stents implanted in millions of heart patients, examining evidence showing the devices may lead to dangerous blood clots.
331586
Patients given drug-coated stents after an acute heart attack are nearly 5 percent more likely to die a year or more later than those with bare metal forms of the arterial scaffolding, new research showed on Tuesday.
557205
Boston Scientific Corp. said last night that sales of its two key products, stents and implantable defibrillators, were slowing down and were likely to drag its third-quarter profit well below Wall Street expectations.
216343
Medical-device maker Boston Scientific Corp. said Thursday that the Food and Drug Administration approved an extended shelf life of nine months for its Taxus Express2 drug-eluting coronary stent system in the United States, up from six months.
700915
The stent maker said it was considering a public stock offering for 18 percent to 25 percent of its Endosurgery division.
33056
The two manufacturers of drug-coated stents used to prop open the arteries of about 3 million people in the U.S. say the devices' benefits outweigh their risks, even though patients could face a small but significant risk of blood clots.
278900
Abbott Laboratories and Medtronic Inc. are poised to seize a third of the $5 billion in annual heart-stent sales with new versions of the drug-coated devices.